EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

18 F-FDG PET/CT Predicts the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation

Wen-Jing Zheng, Yang Xu, Hui Tan, Shu-Guang Chen, Peng-Xiang Wang, Hai-Xiang Sun, Rui-Zhe Li, Hai-Ying Zeng, Yu-Chen Zhong, Jian-Wen Cheng, Jia Fan, Jian Zhou und 2 weitere

Liver Cancer · 05.03.2025 · 14 (5) · 518-538

DOI: 10.1159/000544966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver Cancer, online erschienen am 05.03.2025. Verfasst von Wen-Jing Zheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, PR China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In addition to radical resection, liver transplantation (LTx) is an effective treatment for hepatocellular carcinoma (HCC). However, tumor recurrence limits the efficacy of LTx in some patients. This study investigated the role of 18F-fludeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in predicting the prognosis of patients with HCC after LTx.

Methods

A total of 278 consecutive patients with HCC who underwent pre-LTx PET/CT were divided into derivation (n = 178) and temporal validation (n = 100) cohorts and evaluated for PET/CT values, immunohistochemical (IHC) findings, and DNA sequencing of tumor tissues.

Results

Patients with post-LTx recurrence exhibited significantly higher tumor maximum standardized uptake values (SUVmax) in pre-LTx PET/CT scans. Receiver operating characteristic curve analyses identified the tumor SUVmax to liver SUVmax ratio (TSUVmax/LSUVmax) as the strongest predictor of post-LTx recurrence, with an optimal cutoff value of 1.43. Kaplan-Meier analyses demonstrated that a TSUVmax/LSUVmax >1.43 was associated with a shorter time to recurrence (TTR) and overall survival (OS) in both cohorts (p < 0.001 for both). Multivariate Cox regression analyses confirmed that TSUVmax/LSUVmax >1.43 was an independent risk factor for tumor recurrence in both cohorts. IHC revealed that TSUVmax/LSUVmax >1.43 correlated with higher Ki-67 and CK19 expression. DNA sequencing indicated that tumors with TSUVmax/LSUVmax >1.43 had more mutations and a higher TMB. Furthermore, TSUVmax/LSUVmax >1.43 was significantly associated with mutations in TP53, EPPK1, MDM4, SLAMF7, SDHC, B4GALT3, RXRG, and FCGR family genes, as well as TP53 and PI3K signaling-related alterations.

Conclusions

The preoperative TSUVmax/LSUVmax is a potential predictor of tumor recurrence in patients with HCC following LTx. Its use improves candidate selection and post-LTx management.

Schlagwörter

Stichwörter der Autor:innen

DNA sequencingHepatocellular carcinomaLiver transplantationPositron emission tomographyPrognosis

Autor:innen und Institutionen

  • Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, PR China.
  • Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, PR China.
  • Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, PR China.
  • Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, PR China.
  • Institutes of Biomedical Sciences, Fudan University, Shanghai, PR China.

Zitieren

APA

Zheng, W. J., Xu, Y., Tan, H., Chen, S. G., Wang, P. X., Sun, H. X., Li, R. Z., Zeng, H. Y., Zhong, Y. C., Cheng, J. W., Fan, J., Zhou, J., Shi, H., & Yang, X. R. (2025). 18 F-FDG PET/CT Predicts the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation. Liver Cancer, 14(5), 518-538. https://doi.org/10.1159/000544966

Vancouver

Zheng WJ, Xu Y, Tan H, Chen SG, Wang PX, Sun HX, et al. 18 F-FDG PET/CT Predicts the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation. Liver Cancer. 2025;14(5):518-538. doi:10.1159/000544966

BibTeX
@article{Zheng2025,
  author = {Zheng, Wen-Jing and Xu, Yang and Tan, Hui and Chen, Shu-Guang and Wang, Peng-Xiang and Sun, Hai-Xiang and Li, Rui-Zhe and Zeng, Hai-Ying and Zhong, Yu-Chen and Cheng, Jian-Wen and Fan, Jia and Zhou, Jian and Shi, Hongcheng and Yang, Xin-Rong},
  title = {18 F-FDG PET/CT Predicts the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation},
  journal = {Liver Cancer},
  year = {2025},
  volume = {14},
  number = {5},
  pages = {518--538},
  doi = {10.1159/000544966}
}
Kostenlos starten →